Cargando…

Emergency Use of Tocilizumab in Moderate and Severe COVID-19 Patients over the Prevaccination Stage during the Pandemic in Mexico

INTRODUCTION: COVID-19 has been associated with the overactivation of the immune system; interleukin-6 (IL-6) seems to have a key role, which made its moderation to be proposed as a therapeutic blank. Tocilizumab has been used as part of treatments to modulate the immune response to infections cause...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bernal Luna, Yessica, Esquivel Loza, Alejandro, Garduño García, José de Jesús
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747308/ https://www.ncbi.nlm.nih.gov/pubmed/36524015 http://dx.doi.org/10.1155/2022/6880405

Ejemplares similares

Comparative genomics of prevaccination and modern Bordetella pertussis strains
por: Bart, Marieke J, et al.
Publicado: (2010)

Immune Boosting Explains Regime-Shifts in Prevaccine-Era Pertussis Dynamics
por: Lavine, Jennie S., et al.
Publicado: (2013)

Prevaccination Glycan Markers of Response to an Influenza Vaccine Implicate the Complement Pathway
por: Qin, Rui, et al.
Publicado: (2022)

Review of the temporal and geographical distribution of measles virus genotypes in the prevaccine and postvaccine eras
por: Riddell, Michaela A, et al.
Publicado: (2005)

Correction: Immune Boosting Explains Regime-Shifts in Prevaccine-Era Pertussis Dynamics
por: Lavine, Jennie S., et al.
Publicado: (2014)

Hepatitis B Surface Antigen Seroprevalence among Prevaccine and Vaccine Era Children in Bangladesh
por: Paul, Repon C., et al.
Publicado: (2018)

Critical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid arthritis
por: Hushaw, Linda L, et al.
Publicado: (2010)

Serotypes and antimicrobial susceptibility in clinical isolates of Haemophilus influenzae from Korean children in prevaccination era.
por: Kwak, Y. H., et al.
Publicado: (2000)

Rates of Asymptomatic COVID-19 Infection and Associated Factors in Olmsted County, Minnesota, in the Prevaccination Era
por: Vachon, Celine M., et al.
Publicado: (2022)

NZ's Pharmac to fund tocilizumab for moderate-to-severe cases of COVID-19
Publicado: (2021)

Rubella Seromarkers and Determinants of Infection among Tanzanian Children and Adolescents in Prevaccination Era: Are We in the Right Track?
por: Mirambo, Mariam M., et al.
Publicado: (2017)

Persistent Chaos of Measles Epidemics in the Prevaccination United States Caused by a Small Change in Seasonal Transmission Patterns
por: Dalziel, Benjamin D., et al.
Publicado: (2016)

Association of periodic fasting with lower severity of COVID-19 outcomes in the SARS-CoV-2 prevaccine era: an observational cohort from the INSPIRE registry
por: Horne, Benjamin D, et al.
Publicado: (2022)

Tuberculosis in Mexico and the USA, Comparison of Trends Over Time 1990-2010
por: Hernández-Garduño, Eduardo, et al.
Publicado: (2015)

Seropositivity of SARS-CoV-2 IgG Antibody among People in Dhaka City during the Prevaccination Period
por: Ahmed, Zabed Bin, et al.
Publicado: (2022)

North Carolina public school teachers’ contact patterns and mask use within and outside of school during the prevaccine phase of the COVID-19 pandemic
por: Powers, Kimberly A., et al.
Publicado: (2022)

Early Initiation of Tocilizumab Treatment Against Moderate-to-Severe Myelitis in Neuromyelitis Optica Spectrum Disorder
por: Du, Chen, et al.
Publicado: (2021)

Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia
por: Cardona-Pascual, Ignacio, et al.
Publicado: (2022)

Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia
por: Cardona-Pascual, Ignacio, et al.
Publicado: (2022)

Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia
por: Aomar-Millán, Ismael F., et al.
Publicado: (2022)

Performance Evaluation of a Dengue IgG Rapid Diagnostic Test Designed to Determine Dengue Serostatus as Part of Prevaccination Screening
por: Liberal, Vasco, et al.
Publicado: (2022)

Tocilizumab in severe COVID-19
por: Lucio Liberato, Nicola, et al.
Publicado: (2020)

Prevaccination screening of health care workers for immunity to measles, rubella, mumps and varicella in a developing country. What do we save?
por: Alp, E, et al.
Publicado: (2011)

Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study
por: Jones, G, et al.
Publicado: (2010)

Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial
por: Wang, Dongsheng, et al.
Publicado: (2021)

Tocilizumab for severe COVID-19 pneumonia
por: Mourad, Jean-Jacques, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Lipworth, Brian J, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Piano, Salvatore, et al.
Publicado: (2020)

Novel coronavirus seropositivity and related factors among healthcare workers at a university hospital during the prevaccination period: a cross-sectional study
por: Ogutlu, Aziz, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 among Children Visiting a Tertiary Hospital during the Prevaccination Period, Southwest Region, Saudi Arabia
por: Asseri, Ali Alsuheel, et al.
Publicado: (2022)

Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients
por: Sarhan, Rania M., et al.
Publicado: (2022)

High-Dose Dexamethasone Versus Tocilizumab in Moderate to Severe COVID-19 Pneumonia: A Randomized Controlled Trial
por: Naik, Naveen B, et al.
Publicado: (2021)

Tocilizumab improves clinical outcome in patients with active corticosteroid-resistant moderate-to-severe Graves’ orbitopathy: an observational study
por: Boutzios, Georgios, et al.
Publicado: (2023)

Moderation effects of serotype on dengue severity across pregnancy status in Mexico
por: Annan, Esther, et al.
Publicado: (2023)

Rationale and design of the “Tocilizumab in patients with moderate to severe COVID-19: an open-label multicentre randomized controlled” trial (TOCIBRAS)
por: de Farias, Danielle Leão Cordeiro, et al.
Publicado: (2020)

Tocilizumab is recommended for the treatment of severe COVID-19
por: Zhou, Yonggang, et al.
Publicado: (2020)

Tocilizumab, Adipokines and Severe Complications of COVID-19
por: Fioravanti, Antonella, et al.
Publicado: (2020)

Tocilizumab, netakimab, and baricitinib in patients with mild-to-moderate COVID-19: An observational study
por: Bryushkova, Ekaterina A., et al.
Publicado: (2022)

Emotional Reaction to the First Dose of COVID-19 Vaccine: Postvaccination Decline in Anxiety and Stress among Anxious Individuals and Increase among Individuals with Normal Prevaccination Anxiety Levels
por: Al-Amer, Rasmieh, et al.
Publicado: (2022)

Impact of tocilizumab administration on mortality in severe COVID-19
por: Tsai, Andrew, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3mcgcmsh8h52abf4rhj7sfodil